Adquey (difamilast) NDC 72893-017

NDC codes

FDA NDC Directory

Product NDC (as listed)72893-017Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72893-0017Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
72893-017-07	72893001707	1 TUBE in 1 CARTON (72893-017-07) / 3 g in 1 TUBEMarketed from Feb 25, 2026
72893-017-08	72893001708	1 TUBE in 1 CARTON (72893-017-08) / 27 g in 1 TUBEMarketed from Feb 25, 2026
72893-017-09	72893001709	1 TUBE in 1 CARTON (72893-017-09) / 85 g in 1 TUBEMarketed from Feb 25, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adquey
Generic name (nonproprietary): difamilast
Active ingredients: Difamilast — 10 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Acrotech Biopharma Inc
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 219474
Marketing start: Feb 25, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Phosphodiesterase 4 Inhibitors (Mechanism)
Identifiers: Product ID 72893-017_4b8a157b-05ab-49a7-bd3a-b5a5d0b6f679SPL ID 4b8a157b-05ab-49a7-bd3a-b5a5d0b6f679SPL set ID 46c95e41-fa29-4e11-9d94-0fd4f0291c34RxCUI 2738419, 2738424UNII T3U32GLJ0FUPC 0372893017091, 0372893017084
Pharmacologic class: Phosphodiesterase 4 Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472893001707 followed by a unit qualifier and the quantity

Package 72893-0017-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 25, 2026.

Indications (excerpt from the label)

ADQUEY is indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. ADQUEY is a phosphodiesterase 4 inhibitor indicated for the topical treatment of adults and pediatric patients 2 years of age and older with mild to moderate atopic dermatitis. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)